Abiopharma

🔍 Seidman Becker Caryn (Director)

Company: Clear Secure, Inc. (YOU)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 801,943 shares of Class A Common Stock (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,040,308.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 443,475 shares of Class A Common Stock at $55.17 per share (Direct)
  Date: 2026-06-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 596,833.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 801,943 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,603,888.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: This Form 4 is being filed to report the vesting of a portion of performance restricted stock units ("PSUs") awarded in connection with the Issuer's initial public offering in 2021, each of which represents a contingent right to receive a share of Class A Common Stock following the vesting date. The PSUs were eligible for vesting based on the Issuer's stock price achieving specified share targets over a five-year period of time following the closing of the Issuer's initial public offering in July 2021.
• F2: Represents RSUs automatically withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1, exempt under Rule 16b-3.